These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8676171

  • 1. Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment.
    Ushiyama M, Ikeda S, Suzuki T, Yazawa M, Yanagisawa N, Tsujino S.
    J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):99-102. PubMed ID: 8676171
    [Abstract] [Full Text] [Related]

  • 2. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD.
    Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure.
    Kaufmann H, Oribe E, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1991 Aug; 3(2):143-8. PubMed ID: 1910486
    [Abstract] [Full Text] [Related]

  • 4. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
    Man in 't Veld AJ, Boomsma F, van den Meiracker AH, Julien C, Lenders J, Schalekamp MA.
    J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
    Suzuki T, Sakoda S, Ueji M, Kishimoto S.
    Life Sci; 1985 Feb 04; 36(5):435-42. PubMed ID: 3918223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
    Iida N, Koshikawa S, Akizawa T, Tsubakihara Y, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M.
    Am J Nephrol; 2002 Feb 04; 22(4):338-46. PubMed ID: 12169865
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS, Holmes C, Kaufmann H, Freeman R.
    Clin Auton Res; 2004 Dec 04; 14(6):363-8. PubMed ID: 15666063
    [Abstract] [Full Text] [Related]

  • 10. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans.
    Iwase S, Mano T, Kunimoto M, Saito M.
    J Auton Nerv Syst; 1992 Jun 15; 39(2):159-67. PubMed ID: 1430796
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.
    Freeman R, Landsberg L, Young J.
    Neurology; 1999 Dec 10; 53(9):2151-7. PubMed ID: 10599797
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
    Kachi T, Iwase S, Mano T, Saito M, Kunimoto M, Sobue I.
    Neurology; 1988 Jul 10; 38(7):1091-4. PubMed ID: 3133573
    [Abstract] [Full Text] [Related]

  • 16. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine.
    Freeman R, Young J, Landsberg L, Lipsitz L.
    Neurology; 1996 Dec 10; 47(6):1414-20. PubMed ID: 8960720
    [Abstract] [Full Text] [Related]

  • 17. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
    Azuma T, Suzuki T, Mizuno R, Tsujino S, Kishimoto S, Mizuta E, Ichikawa K.
    Acta Neurol Scand; 1988 May 10; 77(5):409-13. PubMed ID: 3137768
    [Abstract] [Full Text] [Related]

  • 18. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R.
    Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750
    [Abstract] [Full Text] [Related]

  • 19. Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency.
    Wassenberg T, Deinum J, van Ittersum FJ, Kamsteeg EJ, Pennings M, Verbeek MM, Wevers RA, van Albada ME, Kema IP, Versmissen J, van den Meiracker T, Lenders JWM, Monnens L, Willemsen MA.
    J Inherit Metab Dis; 2021 May 12; 44(3):554-565. PubMed ID: 33034372
    [Abstract] [Full Text] [Related]

  • 20. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
    Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, de Freitas AF.
    J Auton Nerv Syst; 1997 Jan 12; 62(1-2):63-71. PubMed ID: 9021651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.